Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma

Estradiol Increases IL-8 Secretion of Normal Human Breast Tissue and Breast Cancer In Vivo

(2014) C. Bendrik et al.   JOURNAL OF IMMUNOLOGY

CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion

(2009) S Singh et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Host CXCR2-Dependent Regulation of Melanoma Growth, Angiogenesis, and Experimental Lung Metastasis

(2009) S. Singh et al.   CANCER RESEARCH

A Role for CXCR2 in Senescence, but What about in Cancer?

(2009) J. C. Acosta et al.   CANCER RESEARCH

Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis

(2009) S. Singh et al.   CLINICAL CANCER RESEARCH

Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy

(2009) J. Yang et al.   MOLECULAR CANCER THERAPEUTICS

The good and the bad of chemokines/chemokine receptors in melanoma

(2009) Ann Richmond et al.   Pigment Cell & Melanoma Research

The role of CXC chemokines and their receptors in cancer

(2008) Jo Vandercappellen et al.   CANCER LETTERS

Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA

(2008) Gabriel J. Villares et al.   CANCER RESEARCH

CXCR2 antagonists for the treatment of pulmonary disease

(2008) R.W. Chapman et al.   PHARMACOLOGY & THERAPEUTICS

CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer

(2008) Timothy R. Donahue et al.   WORLD JOURNAL OF SURGERY